Neuroendocrine activity in untreated heart failure

Area of Science:

• Cardiology
• Endocrinology
• Internal Medicine

Background:

• Heart failure is a complex condition often associated with neuroendocrine system dysregulation.
• Understanding neuroendocrine activity in early or suspected heart failure is crucial for diagnosis and management.

Purpose of the Study:

• To investigate neuroendocrine activity in patients with suspected heart failure.
• To correlate neuroendocrine markers with the severity of left ventricular dysfunction.

Main Methods:

• Studied 60 untreated patients with suspected heart failure and 69 healthy controls.
• Assessed plasma concentrations of atrial natriuretic peptide, adrenaline, noradrenaline, renin activity, and aldosterone.
• Classified patients into unlikely, possible, and definite heart failure groups based on Boston criteria.

Main Results:

• Plasma atrial natriuretic peptide was elevated in definite and possible heart failure.
• Plasma catecholamines (adrenaline and noradrenaline) were increased in definite heart failure.
• Renin activity remained unchanged, and aldosterone was only slightly increased in definite heart failure.
• Significant correlations were found between atrial natriuretic peptide and left ventricular dysfunction severity.

Conclusions:

• Untreated heart failure exhibits evidence of neuroendocrine activation, particularly involving atrial natriuretic peptide and catecholamines.
• The renin-angiotensin-aldosterone system appears less activated in early stages of heart failure compared to other neuroendocrine markers.